Efficacy and Safety of ELGN-2112 on Intestinal Malabsorption in Preterm Infants
Clinical trial NCT05670951 · RECRUITING
Trial details
- NCT number
- NCT05670951
- Sponsor
- Elgan Pharma Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-27
- Primary completion
- 2027-11-01
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.